(HealthDay)—For patients with acute diverticulitis, recurrence is more likely among those undergoing barium enema, according to a study published online Aug. 30 in the Journal of Digestive Diseases.
Sep 7, 2017
0
1
(HealthDay)—Refractory Helicobacter pylori (HP) infection can be successfully treated with goshuyuto and rabeprazole, according to a case report published online Aug. 28 in the Journal of Digestive Diseases.
Sep 5, 2017
0
0
(HealthDay)—For patients undergoing outpatient colonoscopy, a family history questionnaire (FHQ) sent by mail is associated with an increase in available family history and referral for genetic counseling, according to ...
Jun 23, 2017
0
0
(HealthDay)—For patients with Barrett's esophagus (BE), proton pump inhibitor (PPI) but not histamine-2 receptor antagonist (H2RA) use is associated with reduced risk of neoplastic progression, according to research published ...
Feb 15, 2017
0
0
(HealthDay)—Recently developed educational methods have improved patient compliance with bowel preparation for colonoscopy, according to a review published online Jan. 5 in the Journal of Digestive Diseases.
Jan 16, 2017
0
0
(HealthDay)—For Chinese patients with Crohn's disease (CD), 2 mg/kg/day azathioprine (AZA) seems more effective than 1 mg/kg/day, according to a study published online Sept. 21 in the Journal of Digestive Diseases.
Oct 4, 2016
0
0
(HealthDay)—Helicobacter pylori infection is associated with metabolic syndrome, according to a review and meta-analysis published online June 7 in the Journal of Digestive Diseases.
Jun 13, 2016
0
9
(HealthDay)—Younger patients do not have worse clinical presentation of acute diverticulitis, according to a study published online April 23 in the Journal of Digestive Diseases.
Apr 29, 2016
1
5
(HealthDay)—Guidelines, published online Jan. 25 in the Journal of Digestive Diseases, have been developed for endoscopic management of foreign bodies in the upper gastrointestinal tract.
Feb 1, 2016
0
0
(HealthDay)—For patients with liver cirrhosis, low-dose rifaximin is comparable to high-dose rifaximin for reducing serum endotoxin levels, according to a study published online Oct. 16 in the Journal of Digestive Diseases.
Oct 29, 2015
0
3
